Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head and Neck Squamous Cell Carcinomas: A Phase I Study to Reduce Late Toxicity

NCT03396718 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT03396718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03396718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head and Neck Squamous Cell Carcinomas: A Phase I Study to Reduce Late Toxicity
Lead sponsor
Technische Universität Dresden
Phase
Not applicable
Overall status
Recruiting
Start date
November 29, 2018
Completion date
November 30, 2032
Enrollment
304 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

head-and-neck squamous cell carcinoma